Ting Zhang

发表

The Ets transcription factor GABP is a component of the hippo pathway essential for growth and antioxidant defense.

F. Camargo, Xianming Deng, Hongtan Wu, 2013, Cell reports.

Direct Targeting of β-Catenin by a Small Molecule Stimulates Proteasomal Degradation and Suppresses Oncogenic Wnt/β-Catenin Signaling.

Sam W. Lee, K. Westover, Xianming Deng, 2016, Cell reports.

Discovery and Identification of Small Molecules as Methuosis Inducers with in Vivo Antitumor Activities.

Xianming Deng, Ting Zhang, Z. Wang, 2018, Journal of medicinal chemistry.

Modulation of brain cation-Cl− cotransport via the SPAK kinase inhibitor ZT-1a

B. Molyneaux, Xianming Deng, Ting Zhang, 2020, Nature Communications.

Efficacy of novel SPAK inhibitor ZT-1a derivatives (1c, 1d, 1g & 1h) on improving post-stroke neurological outcome and brain lesion in mice

B. Molyneaux, Xianming Deng, Ting Zhang, 2022, Neurochemistry International.

Cep85 Relays Plk1 Activity to Phosphorylated Nek2A for Its Timely Activation in Centrosome Disjunction

Ting Zhang, Canhe Chen, Xianwen Yu, 2018, iScience.

Modulation of brain cation-Cl− cotransport via the SPAK kinase inhibitor ZT-1a

B. Molyneaux, Xianming Deng, Ting Zhang, 2020, Nature Communications.

A cell-based high-throughput screening method based on a ubiquitin-reference technique for identifying modulators of E3 ligases

Xianming Deng, Ting Zhang, Hong-Rui Wang, 2018, The Journal of Biological Chemistry.

Targeting BRK-Positive Breast Cancers with Small-Molecule Kinase Inhibitors.

Xianming Deng, Ting Zhang, Si-Yang Song, 2017, Cancer research.

A Novel Microtubule Inhibitor Overcomes Multidrug Resistance in Tumors.

Xianming Deng, C. Benes, Ting Zhang, 2018, Cancer research.

A new ALK inhibitor overcomes resistance to first and secondgeneration inhibitors in NSCLC

Zheng Wang, Qiyuan Li, Yan Liu, 2021 .

Direct Targeting of β-Catenin by a Small Molecule Stimulates Proteasomal Degradation and Suppresses Oncogenic Wnt/β-Catenin Signaling.

Sam W. Lee, K. Westover, Xianming Deng, 2016, Cell reports.

A new ALK inhibitor overcomes resistance to first‐ and second‐generation inhibitors in NSCLC

Zheng Wang, Qiyuan Li, Yan Liu, 2021, EMBO molecular medicine.